$30.65
-2.53-7.63%
Last update: Nov 6, 7:53 PM
Oscar Health Inc
OSCRNYSE
Oscar Health (OSCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Oscar Health (OSCR) last issued guidance on November 5, 2026 for fiscal year 2026. The company guided revenue in the range of $19B - $19.3B for the period.
Compared to prior guidance, Oscar Health raised its revenue forecast from a prior range of $18.7B - $19B.
Oscar Health has issued 18 guidance updates between February 7, 2024 and November 5, 2026. During this period, the company raised its outlook 6 times, reflecting management's growing confidence in business performance.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.16 | $0.32 | $1.12 | $-0.89 |
| Actual | $0.49 | $1.10 | $2.07 | $-1.24 |
| Surprise | +406.3% | +243.8% | +84.8% | -39.3% |
| Revenue | ||||
| Estimate | $4.72B | $4.76B | $4.91B | $3.16B |
| Actual | $5.14B | $4.88B | $4.65B | $2.81B |
| Surprise | +8.91% | +2.57% | -5.39% | -11.2% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.09 | $2.42 | $1.00 | $0.05 |
| Revenue | ||||
| Consensus | $4.55B | $5.28B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0.49 | $-0.16 | 406.3 % |
| Q2 | Aug 6, 2026 | $1.10 | $0.32 | 243.8 % |
| Q1 | May 6, 2026 | $2.07 | $1.12 | 84.8 % |
| Q4 | Feb 10, 2026 | $-1.24 | $-0.89 | -39.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $5.14B | $4.72B | 8.91 % |
| Q2 | Aug 6, 2026 | $4.88B | $4.76B | 2.57 % |
| Q1 | May 6, 2026 | $4.65B | $4.91B | -5.39 % |
| Q4 | Feb 10, 2026 | $2.81B | $3.16B | -11.2 % |
